Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.

Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.

Home urinalysis test provider Inui had raised $50m from investors including Fosun and Tencent but is being bought by peer Healthy.io for just $9m.

Rabobank was among the investors as the crop protection technology developer publicly launched having raised a total of $66m since inception.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

BBVA, USAA and Power Financial are set to exit wealth management technology provider Personal Capital in an $825m transaction.

OSF Ventures has exited the medical training game developer two years after providing $2m to take its overall funding to $15m.

UCLA has been named as the first university partner of an academic collaboration bridge backed by Evotec, Samsara BioCapital and KCK.

Microsoft's M12 unit and CreditEase Israel Innovation Fund returned for a series C round that took the container coding platform developer's overall funding to $42m.